ScholarIQanswers from OpenAlex & ORCID
Joshua M. Cohen
ResearcherPublications, citations & collaboration network
Joshua M. Cohen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Joshua M. Cohen have?
ScholarIQindexed works
Joshua M. Cohen has 216 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Joshua M. Cohen have?
ScholarIQcitation count
Joshua M. Cohen has 3,054 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Joshua M. Cohen?
ScholarIQh-index
Joshua M. Cohen has an h-index of 28 in OpenAlex.
What is the i10-index of Joshua M. Cohen?
ScholarIQi10-index
Joshua M. Cohen has an i10-index of 62 in OpenAlex.
What is the ORCID of Joshua M. Cohen?
ScholarIQorcid
The ORCID for Joshua M. Cohen is on the source record.
What is the OpenAlex record for Joshua M. Cohen?
ScholarIQopenalex
The OpenAlex for Joshua M. Cohen is on the source record.
What are the most-cited papers on Joshua M. Cohen?
ScholarIQmost cited works
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
Michel D. Ferrari, Hans‐Christoph Diener, Xiaoping Ning, Maja Galić, Joshua M. Cohen, Ronghua Yang, Matthias Müeller, Andrew H. Ahn, Yael Carmeli Schwartz, Melissa Grozinski‐Wolff, Lindsay Janka, Messoud Ashina
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
Robert L. Coleman, Domenica Lorusso, Christine Gennigens, Antonio González-Martı́n, Leslie M. Randall, David Cibula, Bente Lund, Linn Woelber, Sandro Pignata, Frédéric Forget, Andrés Redondo, Signe Diness Vindeløv, Menghui Chen, Jeffrey R. Harris, Margaret S. Smith, Leonardo Nicacio, Melinda Siew Leng Teng, Annouschka Laenen, Reshma Rangwala, Luís Manso, Mansoor Raza Mirza, Bradley J. Monk, Ignace Vergote, Francesco Raspagliesi, Bohuslav Melichar, Lydia Gaba Garcia, Amanda Jackson, Stéphanie Henry, Zdeněk Král, Philipp Harter, Ugo De Giorgi, Maria Bjurberg, Michael A. Gold, David M. O’Malley, Brigitte Honhon, Christof Vulsteke, Eveline Cuypere, Hannelore Denys, Jean‐François Baurain, Claudio Zamagni, Meaghan Tenney, Mary E. Gordinier, William H. Bradley, Matthew Schlumbrecht, Nicola M. Spirtos, Nicole Concin, Sven Mahner, Giovanni Scambia, Charles A. Leath, Robin Farias‐Eisner, Joshua M. Cohen, Carolyn Muller, Sumeet Bhatia
Long-term safety, tolerability, and efficacy of fremanezumab in migraine
Peter J. Goadsby, Stephen D. Silberstein, Paul Yeung, Joshua M. Cohen, Xiaoping Ning, Ronghua Yang, David W. Dodick
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study
Stephen D. Silberstein, Joshua M. Cohen, Michael J. Seminerio, Ronghua Yang, Sait Ashina, Zaza Katsarava
Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine
Stephen D. Silberstein, Lulu Lee, Kavita Gandhi, Timothy Fitzgerald, Jvawnna Bell, Joshua M. Cohen